a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

NCT06718270 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Plasma Cell Leukemia

Interventions

DRUG: CAR-T cells Infusion

Sponsor

Shanghai Changzheng Hospital

Collaborators

[object Object]